UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001606
Receipt No. R000001927
Scientific Title Clinical trial of the new treatment for osteonecrosis of lunate bone using autologous bone marrow stromal cells
Date of disclosure of the study information 2008/12/27
Last modified on 2020/01/06 08:58:50

No. Disposal Last modified on Item of update
1 Insert 2008/12/27 05:17:51
2 Update 2009/12/28 16:48:32 Organization
Organization
Division name
Division name
TEL
Email
Email1
3 Update 2010/06/30 06:22:47 Recruitment status
4 Update 2010/06/30 06:27:07 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2010/12/27 10:05:40 Last name of contact person
Last name of contact person
Organization
Division name
Institute
Organization
Organization
Co-sponsor
6 Update 2011/06/27 05:51:53 Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2012/01/03 15:43:42 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2017/07/19 09:05:39 Blinding
9 Update 2017/07/19 09:08:13 Email
Name of primary sponsor
Organization
10 Update 2017/07/19 09:09:36 Date of protocol fixation
11 Update 2018/01/03 09:16:29 Publication of results
URL related to results and publications
Results
Results
12 Update 2020/01/05 20:56:49 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
13 Update 2020/01/05 20:58:40 Recruitment status
Date of IRB
14 Update 2020/01/06 08:58:50 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.